Evidence-Based Medicine Guidelines
Interferon alfa for neovascular age-related macular degeneration
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interferon Alfa for Neovascular Age-related Macular Degeneration." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456385/all/Interferon_alfa_for_neovascular_age_related_macular_degeneration.
Interferon alfa for neovascular age-related macular degeneration. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456385/all/Interferon_alfa_for_neovascular_age_related_macular_degeneration. Accessed October 9, 2024.
Interferon alfa for neovascular age-related macular degeneration. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456385/all/Interferon_alfa_for_neovascular_age_related_macular_degeneration
Interferon Alfa for Neovascular Age-related Macular Degeneration [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456385/all/Interferon_alfa_for_neovascular_age_related_macular_degeneration.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interferon alfa for neovascular age-related macular degeneration
ID - 456385
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456385/all/Interferon_alfa_for_neovascular_age_related_macular_degeneration
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
